Skip to main content

Table 1 Major studies on transcatheter embolisation of uterine leiomyoma

From: Embolisation of uterine arteries or laparascopic uterine artery ligation as possible treatment of uterine leiomyoma

Author

Number of patients

Follow-up time

Symptoms

Improvement of initial symptoms

Side effects, complications

Worthington-Kirsch et al. (1998) [49]

53

3 months

Bleeding disorder (100%), pelvic pain (58%), anaemia (41%)

Improvement of bleeding disorder and anaemia (88%), of pelvic pain (94%), average volume reduction of myoma (46%)

Postembolisation syndrome (24 patients); nausea/vomiting (22 patients); pelvic pain (20 patients)

Hutchins et al. (1999) [18]

305

12 months

Menorrhagia, pelvic pain

Average volume reduction of the uterus (48%), improvement of menorrhagia, pelvic pain in 92% after 12 months, hysterectomy in six cases, in five cases myomectomy

No severe complications

Goodwin et al. (1999) [13]

60

16.3 months

Bleeding disorder, pelvic pain

Average volume reduction of uterus and myoma for 42.8 and 48.8%; improvement of clinical symptoms in 81%

Postembolisationsyndrome in six cases; one case of amenorrhoea; one case of protracted infection with subsequent hysterectomy

Vashisht et al. (2000) [40]

21

12 months

Menorrhagia (66%), abdominal tension (33%)

Improvement of bleeding disorders in 9/13 cases, improvement of abdominal tension in 2/7 cases, 1 pregnancy

One case of lethal overwhelming septicimia

Ravina et al. (2000) [32]

286

6 months

Bleeding disorders, pelvic pressure

Reduction of myoma volume of 60%, significant improvement of uterine bleeding in 80%, 18 pregnancies

No severe complications

Pelage et al. (2000) [28]

80

24 months

Uterine bleeding, pelvic pain

Improvement of menorrhagia in 90%, three pregnancies

Septical necrosis of myoma requiring hysterectomy in one patient; permanent amenorrhoea in four patients

Siskin et al. (2000) [28]

49

3 months

Bleeding disorder, anaemia, abdominal tension

Average reduction of uterine volume of 47.5%, general improvement of symptoms in 88% of patients

Pelvic pain, nausea/vomiting

Brunereau et al. (2001) [10]

58

3–24 months

Bleeding disorder, pressure, pelvic pain

After 1 year 2/27 patients with no change, 3/27 improvement, 22/27 reduction of uterine size in 26% and of myoma in 51% without symptoms

In three cases fever, headaches, nausea/vomiting

Andersen et al. (2001) [2]

62

12 months

Menorrhagia, pain

In two cases no change, reduced uterine bleeding in 21 patients (96%), reduction of bleeding in 21 patients (70%), less pelvic pain in 18 patients (61%), less pelvic pressure, reduction of uterine volume of 68%, one pregnancy

Endometritis in one patient, allergies in four patients, haematoma due to vascular puncture in two patients

  1. Dt. Ärzteblatt 99 (2002), No. 26, A 1829